Search

After receiving a stem cell transplant for multiple myeloma, John Savarese developed graft-versus-host disease (GVHD). MSK’s specialized GVHD clinic got him back to feeling like himself again.

… Thursday, April 7, 2022 When John Savarese went to see Memorial Sloan Kettering Cancer Center (MSK) hematologic oncologist Doris Ponce for the first time in the fall of 2021, he was not well. “I felt like I was 100 years old,” says the 63-year-old retired air traffic controller and Brooklyn native. “

MSK experts acted quickly to understand the possible effects of COVID-19 on cancer patients and drew on vast experience to explore new treatments.

… Thursday, October 1, 2020 In March 2020, medical oncologist Santosha Vardhana was faced with a new challenge: Many of his patients with lymphoma were becoming infected with the COVID-19 virus. As he saw more cases, Dr. Vardhana noticed a troubling pattern begin to emerge. Patients were managing well

Lab mice who had lactose removed from their diets had a decreased risk of infection with the Enterococcus bacterium.

… Friday, November 29, 2019 Summary An international team led by scientists from MSK has shown for the first time that foods containing lactose, a sugar that’s naturally found in milk and dairy products, help Enterococcus thrive in the gut, at least in mice. Infections with the Enterococcus bacterium are

Learn how 4-year-old Sienna, her family, and the people of MSK Kids inspire each other to continue improving treatments for all children with cancer.

… Thursday, September 4, 2025 When 4-year-old Sienna skips into MSK Kids wearing rainbows and a big smile, the whole space lights up.   “Despite facing this very serious disease and going through difficult treatment, Sienna is always so happy and upbeat,” says her doctor, pediatric hematologist-oncologist

Stem-like cells that make up only a tiny fraction of the total cells in a lung tumor could be the key to stopping the disease’s deadly spread, say researchers at Memorial Sloan Kettering.

… Thursday, October 14, 2021 Imagine you’re about to go on a cross-country trip, stopping at spots along the way to admire local attractions. You’d probably want to have a road atlas handy, containing maps at different scales, covering both the major highways and the roads of smaller cities and towns —

… Monday, September 26, 2022 Memorial Sloan Kettering Cancer Center (MSK) is marking a year since the launch of MSK Telemedicine – an online solution for remote care that has been used for more than 200,000 appointments since its launch last August. MSK Telemedicine, created to provide patients access

Learn about new findings regarding how inherited and acquired genetic mutations cause breast cancer resistance to certain therapies.

… Wednesday, March 4, 2026 Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in  breast cancer patients can interact and drive resistance to certain drugs called CDK4/6 inhibitors. This finding, published in  Nature , suggests a new

Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer.

… Saturday, September 26, 2015 Two pivotal studies published in the New England Journal of Medicine and conducted by Memorial Sloan Kettering researchers offer proof of better treatment options for patients with advanced renal cell carcinoma (RCC), the most common form of kidney cancer. In the studies,

Catch up with some of the patients we got to know in 2017.

… Thursday, December 28, 2017 Everyone touched by cancer has a story to tell. We reconnected with just a few of the inspiring people we met in 2017 to see how they’re doing today. Tim Waples It’s been five years since Tim, a special education teacher from Emerson, New Jersey, completed treatment for non-Hodgkin

At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure.

… Monday, November 11, 2019 At Memorial Sloan Kettering Cancer Center, more than half of patients with gallbladder cancer are diagnosed incidentally following elective cholecystectomy for assumed benign disease. The traditional treatment approach for these patients is re-resection to achieve a cure. Gallbladder